 |
|
|
|
|
|
|
|
 |
Results for 'Ethical Issues in Drug Development' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Industrialization of Drug Discovery
|
May 2005 |
£80 |
50 % |
Merck Druggernaut; The
The Inside Story of a Pharmaceutical Giant
|
March 2005 |
£11.99 |
49.5 % |
Parallel Trade in Pharmaceuticals
Past and future scenarios
|
October 2003 |
£595 |
42 % |
Development and Control of Medicines and Medical Devices
|
July 2004 |
£50 |
35 % |
Development & Control of Medicines and Medical Devices
1st Edition
|
January 2004 |
£50 |
35 % |
Personalized Medicine
Scientific & Commercial Aspects
|
March 2008 |
£1740 |
34.5 % |
RNAi
|
January 2008 |
£2235 |
29.5 % |
CNS Drug Discoveries
What the Future Holds
|
November 2006 |
£1995 |
26 % |
Pharma R&D Fact Book, The
2006
|
November 2007 |
£595 |
25.5 % |
Industry Insight Clinical Trials in India 2007
|
May 2007 |
£400 |
22.4 % |
Clinical Trials in India
Industry Report
|
November 2005 |
£400 |
22.05 % |
Clinical Trails in India
|
January 2008 |
£600 |
21 % |
Handbook of Genome Research
Genomics, Proteomics, Metabolomics, Bioinformatics, Ethical and Legal Issues, Two Volumes
|
June 2005 |
£175 |
21 % |
Pfizer Global and US Analysis
PharmaVitae 2005
|
October 2005 |
£3295 |
18.2 % |
Pharmaceutical Biotechnology
Drug Discovery and Clinical Applications
|
February 2004 |
£115 |
17.5 % |
Neurodegenerative Drug Futures
|
February 2005 |
£995 |
16.1 % |
China Pharmaceuticals & Healthcare
|
September 2006 |
£395 |
16 % |
Clinical Trials Market 2006, The
|
February 2006 |
£1499 |
15.05 % |
Generic Series: An Introduction to the Canadian Generics Market
Key trends and leading companies shaping the market
|
June 2007 |
£2000 |
14.7 % |
Nutrigenomics
Impacts on Markets, Diets, and Health
|
June 2005 |
£1950 |
14.7 % |
Japanese Pharma to 2010
Imminent Transition Towards Globalization Necessary for Survival
|
February 2005 |
£8000 |
14.35 % |
U.S.DNA-Based Diagnostic and Test Market
|
January 2008 |
£985 |
14 % |
Global Generics Industry Report
|
September 2006 |
£550 |
13.65 % |
Russia: Country Scan
|
September 2006 |
£550 |
13.65 % |
Innovations and Trends in Clinical Trials
Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
|
March 2007 |
£1115 |
12.6 % |
Nanotechnology
Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics
|
January 2008 |
£1995 |
12.25 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
11.9 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
11.9 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£795 |
11.9 % |
Bioinformatics
Technical Status and Market Prospects
|
August 2005 |
£2255 |
10.85 % |
Mergers & Acquisitions in Pharmaceuticals
When and how
|
February 2000 |
£165 |
10.85 % |
Commercial Insight: Epilepsy
Companies Committed To The Cause Will Reap The Benefits
|
September 2007 |
£7600 |
10.5 % |
Impact of Genomics on Clinical Trials and Medical Practice, The
|
April 2006 |
£1845 |
10.5 % |
Monoclonal Antibody Therapies
Evolving into a $30 billion market
|
April 2005 |
£8000 |
10.15 % |
Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations)
|
July 2008 |
£1765 |
9.1 % |
Pharmacogenomics: New Technologies
In the Development of Personalized Therapies
|
August 2005 |
£2255 |
8.75 % |
Bioinformatics Markets
Strategies, Business Models and Trends for the Future
|
June 2006 |
£1690 |
8.75 % |
Nanomedicine 2006-2011
|
June 2006 |
£1499 |
8.4 % |
Booming Clinical Trials Market in India
|
November 2007 |
£595 |
7.7 % |
Pain Therapeutics
Drugs, Markets and Companies
|
March 2008 |
£1490 |
7.7 % |
Pharmaceutical Pricing Compendium
A practical guide to the pricing and reimbursement of medicines
|
March 2003 |
£125 |
7.35 % |
Molecular Diagnostics Markets
|
March 2008 |
£1690 |
7.35 % |
Biomarkers
The Expanding Global Market
|
November 2007 |
£2410 |
7 % |
Animal Biotechnology
Technologies, Markets and Companies
|
March 2008 |
£1240 |
6.65 % |
Biological Implants
|
January 2008 |
£1885 |
6.3 % |
Cell Therapy
Technologies, Markets and Companies
|
May 2008 |
£2270 |
6.3 % |
Stem Cell Therapies and Regenerative Medicine
Current Applications and Future Possibilities
|
December 2005 |
£2255 |
6.3 % |
PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2008/2009
|
June 2008 |
£215 |
6.3 % |
Cell Therapy
New Drugs, Markets and Companies
|
March 2008 |
£1515 |
5.95 % |
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008
|
May 2007 |
£215 |
5.95 % |
Nanobiotechnology
|
March 2008 |
£1740 |
5.95 % |
DNA Sequencing
|
February 2008 |
£2235 |
5.6 % |
Molecular Diagnostics
Technologies, Markets and Companies
|
March 2008 |
£1985 |
5.25 % |
Gene Therapy
Technologies, Markets and Companies
|
March 2008 |
£1740 |
5.25 % |
|
|
|
|
